LMWH prophylaxis
Showing 1 - 25 of 2,887
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
Cancer Associated Thrombosis for Rivaroxaban - United States
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, ConnecticutMany Locations
May 18, 2022
Venous Thromboembolism, Pulmonary Embolism Trial in Baltimore (VTE prophylaxis with Enoxaparin 30mg BID, VTE prophylaxis with
Completed
- Venous Thromboembolism
- Pulmonary Embolism
- VTE prophylaxis with Enoxaparin 30mg BID
- VTE prophylaxis with Aspirin 81mg BID
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 3, 2022
LMWH Compliance in Pregnancy
Recruiting
- Venous Thromboembolism
- Antenatal Deep Vein Thrombosis
- Smart sharps bin - collects data on compliance
-
Cork, IrelandCork University Maternity Hospital
Sep 23, 2021
Colorectal Cancer Metastatic, Thromboembolism Trial in Spain (Tinzaparin)
Not yet recruiting
- Colorectal Cancer Metastatic
- Thromboembolism
-
Santiago De Compostela, A Coruña, Spain
- +32 more
Nov 23, 2022
Intravenous Continuous LMWH Seems to be Safe Alternative to UFH
Completed
- Refractory Respiratory Failure
- No intervention, just retrospective analysis of data.
-
Prague, CzechiaUnoversity Hospital Motol, Department of Anaesthesiology and Int
Aug 22, 2023
Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose
Recruiting
- Venous Thromboembolism
- Prophylactic low molecular weight heparin
- Low molecular weight heparin and low-dose aspirin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jan 18, 2023
Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)
Recruiting
- Deep-Venous Thrombosis
- IPD Device delivered by Converis
- Fraxiparine
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Apr 6, 2022
Chemical Venous Thromboembolism Prophylaxis in Trauma
Enrolling by invitation
- Thromboembolism, Venous
-
Dallas, TexasMethodist Dallas Medical Center Pharmacy
Sep 1, 2023
Blood Clot, Trauma Trial in Canada, United States (Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH))
Completed
- Blood Clot
- Trauma
- Acetylsalicylic acid
- Low Molecular Weight Heparin (LMWH)
-
Tucson, Arizona
- +20 more
Oct 7, 2022
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Tumors Malignant, Surgery, Venous Thromboembolism Trial in Hamilton (Apixaban 2.5 milligram)
Completed
- Neoplasms Malignant
- +4 more
- Apixaban 2.5 milligram
-
Hamilton, Ontario, Canada
- +1 more
Apr 14, 2022
Deep Venous Thrombosis, Pulmonary Embolism Trial in Worldwide (Low dose nadroparin, Intermediate dose nadroparin, Low dose
Completed
- Deep Venous Thrombosis
- Pulmonary Embolism
- Low dose nadroparin
- +7 more
-
New York, New York
- +71 more
May 21, 2022
Dose Regimen of Intravenous Unfractionated Heparin and Low
Active, not recruiting
- COVID-19
- +3 more
-
Gent, BelgiumGhent University Hospital
Oct 24, 2022
Morbid Obesity Trial in Erbil (Bemiparin 3500, Bemiparin 5000 IU)
Recruiting
- Morbid Obesity
- Bemiparin 3500
- Bemiparin 5000 IU
-
Erbil, Kurdistan Region, IraqHawler Medical university
Jan 8, 2023
Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia Trial in Amsterdam (Nadroparin Injectable Product)
Recruiting
- Aneurysmal Subarachnoid Hemorrhage
- Delayed Cerebral Ischemia
- Nadroparin Injectable Product
-
Amsterdam, NetherlandsAmsterdam University Medical Centers
Feb 15, 2022
Venous Thromboembolic Disease, Pulmonary Embolism, Deep Venous Thrombosis Trial (Bleeding-risk based prophylaxis strategy during
Not yet recruiting
- Venous Thromboembolic Disease
- +2 more
- Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge
- Routine VTE prophylaxis in hospital
- (no location specified)
Aug 1, 2021
Chronic Kidney Diseases, Atrial Fibrillation, Stroke Trial (Apixaban 2.5 milligram Oral Tablet)
Not yet recruiting
- Chronic Kidney Diseases
- +8 more
- Apixaban 2.5 milligram Oral Tablet
- (no location specified)
Jan 8, 2023
Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])
Not yet recruiting
- Liver Cirrhosis
- Apixaban 5 MG [Eliquis]
- Edoxaban 60 MG [Lixiana]
- (no location specified)
May 19, 2023
Venous Thromboembolism, Venous Thrombosis Trial in Moscow (SCD, GCS, LMWH)
Completed
- Venous Thromboembolism
- Venous Thrombosis
- SCD
- +2 more
-
Moscow, Russian Federation
- +1 more
Jan 13, 2021
Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)
Not yet recruiting
- Venous Thromboembolism
- Peak value anti-Xa
- +2 more
- (no location specified)
May 15, 2022
Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy
Not yet recruiting
- Pregnancy Complications
- +3 more
- Viscoelastic haemostasis monitor output
- (no location specified)
Oct 25, 2021
Pulmonary Embolism, Trauma, Venous Thromboembolism Trial in London (Cook 'Celect' retrievable inferior vena cava filter)
Completed
- Pulmonary Embolism
- +2 more
- Cook 'Celect' retrievable inferior vena cava filter
-
London, Ontario, CanadaVictoria Hospital
Feb 25, 2021
Thromboprophylaxis Appropriateness in Hospitalized Medical
Recruiting
- Deep Vein Thrombosis
- +2 more
-
Baghdad, IraqEUC
Oct 21, 2022